Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 428 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Acute Kidney Insufficiency Clear all

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: BayCare Health System; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Clearwater, Florida • New Port Richey, Florida • Safety Harbor, Florida + 1 more

Conditions: Acute Kidney Injury
Interventions: Allogeneic HB-adMSCs, Normal Saline; Drug
Lead sponsor: Hope Biosciences LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Birmingham, Alabama • San Francisco, California • Houston, Texas

Conditions: Deceased Donor Kidney Transplant, Acute Kidney Injury, Delayed Graft Function, End Stage Renal Disease, Graft Failure
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: Not listed
Enrollment: 1,679 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 17
States / cities: New Haven, Connecticut • Baltimore, Maryland • Waltham, Massachusetts + 7 more

Conditions: Acute Kidney Injury
Interventions: Conservative dialysis strategy, TIW dialysis strategy; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 100 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Kidney Injury, Immune Deficiency
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Acute Kidney Injury, Dialysis Hypotension
Interventions: ORKID Bundled Intervention, Furosemide; Other · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Heart Failure
Interventions: Tolvaptan, placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Acute Kidney Injury, Kidney; Disease, Acute, Dialysis Related Complication
Interventions: Dialysis; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 4
States / cities: San Francisco, California • St Louis, Missouri • Nashville, Tennessee + 1 more

Conditions: Critical Illness, Acute Kidney Injury
Interventions: 0.9% Saline, Physiologically-balanced isotonic crystalloid; Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 14,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Blood Pressure, Kidney Failure, Chronic, Dietary Modification
Interventions: Nepro; Dietary Supplement
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Acute Kidney Injury
Interventions: Vasopressin, Phenylephrine; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cognitive Disorders, Delirium, Acute Kidney Injury
Interventions: Ketamine, Propofol; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 75 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Kidney Injury (AKI)
Interventions: Not listed
Lead sponsor: University Hospital Muenster; Other
Eligibility: 18 Years and older
Enrollment: 10,568 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Acute Renal Failure
Interventions: TPN nutritional supplement; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Respiratory Distress Syndrome, Cardiac Failure, Extracorporeal Membrane Oxygenation Complication, Respiratory Failure, Renal Failure, Critical Illness, Pulmonary Disease
Interventions: Ventilator; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Acute Kidney Failure
Interventions: Furosemide; Drug
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Acute Kidney Injury, Heart Failure
Interventions: Not listed
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Acute Kidney Injury
Interventions: AKI Prevention Toolkit, Technical Assistance (TA), Virtual Learning Collaborative (VLC), Automated Surveillance Reporting (ASR); Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: Not listed
Enrollment: 10,252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Nashville, Tennessee • White River Junction, Vermont

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Months to 25 Years
Enrollment: 5,237 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 18
States / cities: Birmingham, Alabama • Palo Alto, California • Aurora, Colorado + 14 more

Conditions: Glomerular Filtration Rate, Acute Kidney Injury
Interventions: MP-3180, Iohexol comparator; Drug · Other
Lead sponsor: MediBeacon; Industry
Eligibility: 22 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: Not listed
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Kidney Injury, Dialysis; Complications
Interventions: Continuous Renal Replacement Therapy (CRRT); Device
Lead sponsor: University of Alberta; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Kidney Injury, HIE
Interventions: Single Dose Theophylline, Repeat Dose Theophylline; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 1 Hour to 18 Hours
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Search by objective public record fields.

Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury

Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

Deceased Donor Biomarkers and Recipient Outcomes

Recovery After Dialysis-Requiring Acute Kidney Injury

Immunoparalysis in Acute Kidney Injury After Cardiac Surgery

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis

The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study

Liberation From Acute Dialysis

Saline Against Lactated Ringers or Plasmalyte in the Emergency Department

Acute Effects of Nutrition Supplementation on Treatment Efficiency and Hemodynamics During Dialysis

Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery

The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction

Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury

Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure

Biomarkers, Genomics, Physiology in Critically Ill and ECMO Patients

Protocol to Assess the Severity of Acute Kidney Injury

Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

IMPROVE AKI Cluster-Randomized Trial

AKI in Thoracic and Abdominal Surgery

Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes

Pharmacokinetics of MP-3180 in Healthy Volunteers

Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury

LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)

Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage